Expression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVA.
CD8(+) T cell responses to vaccinia virus are directed almost exclusively against early gene products. The attenuated strain modified vaccinia virus Ankara (MVA) is under evaluation in clinical trials of new vaccines designed to elicit cellular immune responses against pathogens including Plasmodium...
Main Authors: | Orubu, T, Alharbi, N, Lambe, T, Gilbert, S, Cottingham, MG |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2012
|
Similar Items
-
Expression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVA.
by: Toritse Orubu, et al.
Published: (2012-01-01) -
Poxviral promoters for improving the immunogenicity of MVA delivered vaccines
by: Naif Khalaf Alharbi
Published: (2019-01-01) -
Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoter
by: Alharbi, N, et al.
Published: (2015) -
Utilizing poxviral vectored vaccines for antibody induction-progress and prospects.
by: Draper, S, et al.
Published: (2013) -
Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice
by: Martin C. Langenmayer, et al.
Published: (2023-06-01)